Concurrent chemoradiotherapy with low dose weekly gemcitabine in medically inoperable muscle-invasive bladder cancer patients

被引：0
|
作者：
B. M. Atasoy
F. Dane
I. Alsan Cetin
Z. Ozgen
A. Ucuncu Kefeli
R. Ibrahimov
N. S. Turhal
U. Abacioglu
L. Turkeri
机构：
[1] Marmara University School of Medicine,Department of Radiation Oncology
[2] Marmara University School of Medicine,Division of Medical Oncology, Department of Internal Medicine
[3] Ministry of Health-Marmara University Pendik Education and Research Hospital,Radiation Oncology Clinic
[4] Marmara University School of Medicine,Department of Urology
[5] S.B. Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi,undefined
[6] Radyasyon Onkolojisi Klinigi,undefined
来源：
Clinical and Translational Oncology | 2014年 / 16卷
关键词：
Bladder cancer; Concurrent gemcitabine; Medically unfit patients; Radiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：91 / 95
页数：4
相关论文
共 50 条
  • [31] Bladder sparing options for muscle-invasive bladder cancer
    Laukhtina, Ekaterina
    Moschini, Marco
    Teoh, Jeremy Yuen-Chun
    Shariat, Shahrokh F.
    CURRENT OPINION IN UROLOGY, 2024, 34 (06) : 471 - 476
  • [32] Radiotherapy for Muscle-invasive Bladder Cancer in Very Elderly Patients
    Maebayashi, Toshiya
    Ishibashi, Naoya
    Aizawa, Takuya
    Sakaguchi, Masakuni
    Sato, Katsuhiko
    Matsui, Tsuyoshi
    Yamaguchi, Kenya
    Takahashi, Satoru
    ANTICANCER RESEARCH, 2016, 36 (09) : 4763 - 4769
  • [33] Bladder preserving strategies for muscle-invasive bladder cancer
    Merseburger, Axel S.
    Matuschek, Ira
    Kuczyk, Markus A.
    CURRENT OPINION IN UROLOGY, 2008, 18 (05) : 513 - 518
  • [34] The role of biomarkers in bladder preservation management of muscle-invasive bladder cancer
    Mitin, Timur
    Choudhury, Ananya
    WORLD JOURNAL OF UROLOGY, 2019, 37 (09) : 1767 - 1772
  • [35] Neoadjuvant Chemoradiotherapy Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer: Analysis of Efficacy and Safety in 119 Patients
    Fujiwara, Motohiro
    Tanaka, Hajime
    Kobayashi, Masaki
    Nakamura, Yuki
    Fan, Bo
    Ishikawa, Yudai
    Fukuda, Shohei
    Toda, Kazuma
    Yoshida, Soichiro
    Yokoyama, Minato
    Yoshimura, Ryoichi
    Fujii, Yasuhisa
    CLINICAL GENITOURINARY CANCER, 2024, 22 (02) : 193 - 200.e1
  • [36] The Significance of Neutrophil-to-Lymphocyte Ratio and Combined Chemoradiotherapy in Patients Undergoing Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
    Wu, Chun-Te
    Huang, Yun-Ching
    Chen, Wen-Cheng
    Chen, Miao-Fen
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 13125 - 13135
  • [37] OUTCOMES OF BLADDER PRESERVATION THERAPY ON SURVIVAL IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER
    Ozaydin, Sukru
    Atas, Erman
    Karadurmus, Nuri
    Emirzeoglu, Levent
    Arpaci, Fikret
    ARCHIVOS ESPANOLES DE UROLOGIA, 2020, 73 (01): : 41 - 46
  • [38] Concurrent urologic and palliative care after cystectomy for treatment of muscle-invasive bladder cancer
    Rabow, Michael W.
    Benner, Carly
    Shepard, Nancy
    Meng, Maxwell V.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (06) : 267.e23 - 267.e29
  • [39] The efficacy of trimodal chemoradiotherapy with gemcitabine and cisplatin as a bladder-preserving strategy for the treatment of muscle-invasive bladder cancer: a single-arm phase II study
    Kobayashi, Keita
    Matsumoto, Hiroaki
    Misumi, Taku
    Ito, Hideaki
    Hirata, Hiroshi
    Nagao, Kazuhiro
    Matsuyama, Hideyasu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (10) : 1201 - 1207
  • [40] Actionable mutations in muscle-invasive bladder cancer
    Bambury, Richard M.
    Rosenberg, Jonathan E.
    CURRENT OPINION IN UROLOGY, 2013, 23 (05) : 472 - 478
12345